MONTPELIER — Vermont’s attorney general says the state will receive $1.1 million as part of a national settlement with pharmaceutical manufacturer GlaxoSmithKline over allegations that the company deceptively marketed a diabetes drug.
The complaint accuses GlaxoSmithKline LLC of engaging in unfair and deceptive practices by misrepresenting Avandia’s cardiovascular risks and safety profile.
Vermont Attorney General William Sorrell said Thursday that GlaxoSmithKline has reached a $90 million settlement with 37 other attorneys general and has agreed to change how it markets and promotes diabetes drugs.MORE IN Vermont NewsRUTLAND-Vermont's largest electric utility says its customers won't be seeing any increases in... Full Story
- Most Popular
- Most Emailed
- VIDEO: The play that's under appeal from the DIII state football championships
- VIDEO: Downhill excitement at Silverheels Cup at Okemo
- VIDEO: Woodstock takes on U-32 football
- VIDEO: 2013 Vermont Amateur Golf Tournament
- VIDEO: Police investigate Pittsford homicide
- VIDEO: Rutland High School Graduation